首页> 美国卫生研究院文献>Cardiovascular Diseases >Limited-access coronary artery bypass grafting. The Texas Heart Institute experience.
【2h】

Limited-access coronary artery bypass grafting. The Texas Heart Institute experience.

机译:受限进入冠状动脉搭桥术。德州心脏研究所的经验。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Limited-access coronary artery bypass grafting, without the aid of cardiopulmonary bypass, is being performed with increased frequency, but its indications are not well defined. To determine the outcome of, and indications for, this procedure, we analyzed our experience with limited-access coronary artery bypass grafting. Between February 1996 and June 1998, 84 patients underwent limited-access coronary artery bypass grafting at our institution. We retrospectively divided these patients into 2 groups: a high-risk group with complex disease and multiple comorbidities (n = 56), and a low-risk group with uncomplicated disease (n = 28). There were 2 perioperative deaths (2%), and both of them occurred in high-risk cases. Early and late complications included myocardial infarction (2 cases), recurrent angina necessitating revascularization (2 cases), and multisystem dysfunction (1 case). Compared with conventional bypass grafting, limited-access coronary artery bypass grafting offered a smaller skin incision, fewer arrhythmias, less blood loss, less need for inotropic drugs, shorter hospitalization, lower cost, and quicker recovery time. Limited-access coronary artery bypass grafting might have a role in treating high-risk patients who have complex disease and require single-vessel bypass. Anastomosis can be challenging, however, if the target coronary artery is small, calcific, or intramyocardial. Moreover, the long-term results are unknown. Therefore, nonselective use of limited-access coronary artery bypass grafting is unjustified.
机译:在不借助心肺旁路的情况下,受限进入冠状动脉旁路移植术的频率越来越高,但其适应症尚不明确。为了确定该手术的结果和适应症,我们分析了有限通路冠状动脉搭桥术的经验。在1996年2月至1998年6月之间,我们机构对84例患者进行了有限的冠状动脉搭桥术。我们将这些患者回顾性分为两组:高危组,复杂疾病和多种合并症(n = 56)和低危组,无复杂疾病(n = 28)。围手术期死亡2例(占2%),均为高危病例。早期和晚期并发症包括心肌梗塞(2例),复发性心绞痛需要血运重建(2例)和多系统功能障碍(1例)。与传统的旁路移植术相比,进入受限的冠状动脉旁路移植术具有更小的皮肤切口,更少的心律失常,更少的失血量,更少的正性肌力药物需求,更短的住院时间,更低的成本以及更快的恢复时间。受限通路冠状动脉搭桥术可能在治疗复杂疾病,需要单支血管搭桥的高危患者中发挥作用。但是,如果目标冠状动脉小,钙化或心肌内,则吻合可能会很困难。而且,长期结果还未知。因此,限制进入冠状动脉旁路移植术的非选择性使用是不合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号